Cochran JS - Search Results

1

The seminoma decoy: measurement of serum human chorionic gonadotropin in patients with seminoma.

Cochran JS. Cochran JS. J Urol. 1976 Oct;116(4):465-6. doi: 10.1016/s0022-5347(17)58860-6. J Urol. 1976. PMID: 1053336

2

Serum alpha-fetoprotein and human chorionic gonadotropin in patients with seminoma.

Lange PH, Nochomovitz LE, Rosai J, Fraley EE, Kennedy BJ, Bosl G, Brisbane J, Catalona WJ, Cochran JS, Comisarow RH, Cummings KB, deKernion JB, Einhorn LH, Hakala TR, Jewett M, Moore MR, Scardino PT, Streitz JM. Lange PH, et al. Among authors: cochran js. J Urol. 1980 Oct;124(4):472-8. doi: 10.1016/s0022-5347(17)55500-7. J Urol. 1980. PMID: 6158584

3

The endocrinology of human chorionic gonadotropin-secreting testicular tumors: new methods in diagnosis.

Cochran JS, Walsh PC, Porter JC, Nicholson TC, Madden JD, Peters PC. Cochran JS, et al. J Urol. 1975 Oct;114(4):549-55. doi: 10.1016/s0022-5347(17)67080-0. J Urol. 1975. PMID: 1242015

4

Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors.

Cochran JS, Walsh PC, Porter JC, Nicholson TP, Peters PC. Cochran JS, et al. Surg Forum. 1974;25(0):542-3. Surg Forum. 1974. PMID: 4474717 No abstract available.

5

Private practice experience with radical surgical treatment of cancer of prostate.

Cochran JS, Kadesky MC. Cochran JS, et al. Urology. 1981 Jun;17(6):547-9. doi: 10.1016/0090-4295(81)90072-8. Urology. 1981. PMID: 7245444

6

Immunobiology of reproductive processes in men. Current concepts.

Cochran JS. Cochran JS. Urology. 1974 Oct;4(4):367-77. doi: 10.1016/0090-4295(74)90001-6. Urology. 1974. PMID: 4608678 Review. No abstract available.

7

A private practice experience with adenocarcinoma of the prostate in men less than 50 years old.

Cochran JS, Kadesky MC. Cochran JS, et al. J Urol. 1981 Feb;125(2):220-1. doi: 10.1016/s0022-5347(17)54978-2. J Urol. 1981. PMID: 7206061

8

Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.

Fulgham PF, Cochran JS, Denman JL, Feagins BA, Gross MB, Kadesky KT, Kadesky MC, Clark AR, Roehrborn CG. Fulgham PF, et al. Among authors: cochran js. J Urol. 1998 Dec;160(6 Pt 1):2041-6. doi: 10.1097/00005392-199812010-00028. J Urol. 1998. PMID: 9817319 Clinical Trial.

9

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer.

Freedland SJ, de Almeida Luz M, De Giorgi U, Gleave M, Gotto GT, Pieczonka CM, Haas GP, Kim CS, Ramirez-Backhaus M, Rannikko A, Tarazi J, Sridharan S, Sugg J, Tang Y, Tutrone RF Jr, Venugopal B, Villers A, Woo HH, Zohren F, Shore ND; EMBARK Study. Freedland SJ, et al. N Engl J Med. 2023 Oct 19;389(16):1453-1465. doi: 10.1056/NEJMoa2303974. N Engl J Med. 2023. PMID: 37851874 Clinical Trial.

10

A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result.

Donovan MJ, Noerholm M, Bentink S, Belzer S, Skog J, O'Neill V, Cochran JS, Brown GA. Donovan MJ, et al. Among authors: cochran js. Prostate Cancer Prostatic Dis. 2015 Dec;18(4):370-5. doi: 10.1038/pcan.2015.40. Epub 2015 Sep 8. Prostate Cancer Prostatic Dis. 2015. PMID: 26345389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters